- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03763097
Sonographic Evaluation of the Single-incision Needleless (Contasure-needleless®) Mini-sling Placement to Predict Success
Transperineal ultrasonography is gaining importance in preoperative and postoperative evaluation of the patient with urinary incontinence with allowing well detailed information about the anterior compartment.
There is little evidence that transperineal sonography can aid surgeons to predict the success or failure after mid-urethral slings.
We aimed to investigate the efficacy of sonography in mini-sling operations to predict the success or failure.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Women who are scheduled for anti-incontinence operation due to their stress urinary incontinence will be pre- and postoperatively evaluated by transperineal and introital ultrasound.
Patients will be followed for at least 1 year.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bartin, Turkey
- Bartin State Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with clinically stress urinary incontinence
- Patients who claim that their condition severely impair their quality of life
- Patients who are failed on conservative management (life style changes and pelvic floor exercises)
Exclusion Criteria:
- Patients who have unregulated diabetes mellitus (they will be included after appropriate and sustainable blood glucose regulation)
- Patients who have neurological condition that may affect the incontinence
- Patients who have psychiatric disease that may affect the subjective evaluation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
participants
Patients who are scheduled for single-incision needleless (Contasure-needleless®) mini-sling for their stress urinary incontinence.
They will be assessed by Pelvic floor ultrasound
|
Pelvic floor ultrasound will include transperineal and introital ultrasound
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The correlation of failure with the sonographic features of the mesh
Time Frame: Evaluation at postoperative 1st and 4th weeks
|
Patients will be accepted as failure if their stress test is positive Sonographic features of the mesh includes the shape of the mesh, the distance to the mid-urethra, the position related to the proximal urethra and the angle between the mesh arms on coronal axis
|
Evaluation at postoperative 1st and 4th weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nocturia
Time Frame: Evaluation at postoperative 1st and 4th weeks and preoperatively
|
The nocturia episodes will be evaluated by a "non-validated" Likert scale (between 0-3).
Minimum and minimum scores are between 0 and 3. "0" will mean no episode of urinating during the sleep.
"1" will mean one episode of nocturia.
"2" will mean two episodes of nocturia.
"3" will mean three or more episodes of nocturia.
Higher values represent worse outcome.
|
Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Urge symptoms
Time Frame: Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Michigan Incontinence Severity Index (M-ISI) scale will be used to assess subjective outcome including urge symptoms.
This scale has ten items, consisting of a total M-ISI domain (the sum of items 1-8) and a distinct Bother domain (the sum of items 9 and 10).
The total M-ISI score consists of three subdomains (items 1-3 for stress urinary incontinence [SUI], items 4-6 for urge urinary incontinence [UUI], and items 7 and 8 for Pad usage [PU].
The responses for each item range from 0 to 4 on a Likert-type scale, with higher values representing greater symptoms and greater bother.
Total domain and subdomain scores are obtained by simply adding the respective answers.
The minimally important difference has been determined for the following domains/subdomains: total M-ISI (4 points), SUI (2 points), UUI (2 points), and PU (1 point).
|
Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Subjective success
Time Frame: Evaluation at postoperative 1st and 4th weeks
|
Patient Global Improvement of Improvement will be used to assess the subjective success
|
Evaluation at postoperative 1st and 4th weeks
|
POP-Q
Time Frame: Evaluation at postoperative 1st and 4th weeks and preoperatively
|
POP-Q measurements will be assessed to measure the pelvic floor prolapse if exist
|
Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Anterior compartment mobility distances
Time Frame: Evaluation at postoperative 1st and 4th weeks and preoperatively
|
On maximal Valsalva maneuver: Bladder neck descent (mm), pubourethral distance (mm), urethral thickness (mm, measured at proximal, mid and distal portions) and urethral length (mm)
|
Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Anterior compartment mobility angles
Time Frame: Evaluation at postoperative 1st and 4th weeks and preoperatively
|
On maximal Valsalva maneuver: Proximal urethral rotation (degree), retrovesical angle (degree)
|
Evaluation at postoperative 1st and 4th weeks and preoperatively
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ba2018-4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence,Stress
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
Clinical Trials on Pelvic floor ultrasound
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingUrinary Incontinence | Constipation | Sexual Dysfunction | Pelvic Organ Prolapse | Pelvic Pain | Pelvic Floor Disorders | Anal Sphincter Injury | Anal Incontinence | Obstetric Trauma
-
Sheba Medical CenterUnknown
-
Croydon University HospitalCompletedObstetric Anal Sphincter Injury
-
Assiut UniversityUnknown
-
Universitaire Ziekenhuizen KU LeuvenUnknownUrinary Incontinence | Constipation | Sexual Dysfunction | Pelvic Organ Prolapse | Pregnancy Related | Body Image | Anal Incontinence | Postpartum Disorder | Anorectal DisorderBelgium
-
Federal University of São PauloCompletedUrinary Incontinence | Postoperative PeriodBrazil
-
Al-Azhar UniversityCompletedEffects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian WomenPregnancy, Childbirth and Puerperal Disorders
-
University Hospitals of North Midlands NHS TrustActive, not recruitingPelvic Floor DysfunctionUnited Kingdom
-
Cairo UniversityNot yet recruitingPelvic Floor Disorders | Chronic Perineal PainEgypt
-
South Valley UniversityNot yet recruiting